Pay-For-Delay, REMS Reform Legislation Making (Slow) Progress In House
Executive Summary
CREATES Act gets a hearing, but Judiciary committee members spend much of their time asking questions about basic concepts of FDA review.
You may also be interested in...
Ways And Means Drug Pricing Hearing Emphasizes Repetitive, Years-Old Questions
There was little on specific legislative proposals and a lot of time discussing broad questions that Congress has been asking for years about drug pricing.
US FDA Wants To Predict ANDA Complete Response Responses
Generic industry, FDA discuss potential ways to increase transparency so agency can better estimate when – and even whether – an ANDA receiving a complete response will be returned.
US FDA Wants To Predict ANDA Complete Response Responses
Generic industry, FDA discuss potential ways to increase transparency so agency can better estimate when – and even whether – an ANDA receiving a complete response will be returned.